Cargando…
COVID‐19 in dimethyl fumarate‐treated patients with multiple sclerosis
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314911/ https://www.ncbi.nlm.nih.gov/pubmed/32588182 http://dx.doi.org/10.1007/s00415-020-10015-1 |
| _version_ | 1783550152127021056 |
|---|---|
| author | Mantero, Vittorio Abate, Lucia Basilico, Paola Balgera, Roberto Salmaggi, Andrea Nourbakhsh, Bardia Cordano, Christian |
| author_facet | Mantero, Vittorio Abate, Lucia Basilico, Paola Balgera, Roberto Salmaggi, Andrea Nourbakhsh, Bardia Cordano, Christian |
| author_sort | Mantero, Vittorio |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7314911 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73149112020-06-25 COVID‐19 in dimethyl fumarate‐treated patients with multiple sclerosis Mantero, Vittorio Abate, Lucia Basilico, Paola Balgera, Roberto Salmaggi, Andrea Nourbakhsh, Bardia Cordano, Christian J Neurol Letter to the Editors Springer Berlin Heidelberg 2020-06-25 2021 /pmc/articles/PMC7314911/ /pubmed/32588182 http://dx.doi.org/10.1007/s00415-020-10015-1 Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editors Mantero, Vittorio Abate, Lucia Basilico, Paola Balgera, Roberto Salmaggi, Andrea Nourbakhsh, Bardia Cordano, Christian COVID‐19 in dimethyl fumarate‐treated patients with multiple sclerosis |
| title | COVID‐19 in dimethyl fumarate‐treated patients with multiple sclerosis |
| title_full | COVID‐19 in dimethyl fumarate‐treated patients with multiple sclerosis |
| title_fullStr | COVID‐19 in dimethyl fumarate‐treated patients with multiple sclerosis |
| title_full_unstemmed | COVID‐19 in dimethyl fumarate‐treated patients with multiple sclerosis |
| title_short | COVID‐19 in dimethyl fumarate‐treated patients with multiple sclerosis |
| title_sort | covid‐19 in dimethyl fumarate‐treated patients with multiple sclerosis |
| topic | Letter to the Editors |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314911/ https://www.ncbi.nlm.nih.gov/pubmed/32588182 http://dx.doi.org/10.1007/s00415-020-10015-1 |
| work_keys_str_mv | AT manterovittorio covid19indimethylfumaratetreatedpatientswithmultiplesclerosis AT abatelucia covid19indimethylfumaratetreatedpatientswithmultiplesclerosis AT basilicopaola covid19indimethylfumaratetreatedpatientswithmultiplesclerosis AT balgeraroberto covid19indimethylfumaratetreatedpatientswithmultiplesclerosis AT salmaggiandrea covid19indimethylfumaratetreatedpatientswithmultiplesclerosis AT nourbakhshbardia covid19indimethylfumaratetreatedpatientswithmultiplesclerosis AT cordanochristian covid19indimethylfumaratetreatedpatientswithmultiplesclerosis |